Clincosm LogoSign in Get a demo

Breast Neoplasms

Showing 51 - 75 of 763
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Breast Tumors, Colon Cancer Trial in United States (AZD6244, Dacarbazine, Erlotinib)

Active, not recruiting
  • Breast Cancer
  • +7 more
  • Detroit, Michigan
  • +3 more
Dec 22, 2022

Breast Tumors Trial in Israel, Korea, Republic of, United States (Atezolizumab (MPDL3280A), an engineered anti-programmed

Active, not recruiting
  • Breast Neoplasms
  • Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (PD-L1) antibody
  • +7 more
  • Birmingham, Alabama
  • +26 more
Dec 21, 2022

Breast Tumors Trial in United States (endocrine therapy alone without radiotherapy)

Active, not recruiting
  • Breast Neoplasms
  • endocrine therapy alone without radiotherapy
  • Stanford, California
  • +12 more
Dec 20, 2022

Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

Active, not recruiting
  • Breast Neoplasms
  • Chuo Ku, Japan
  • +1 more
Dec 19, 2022

Breast Tumors Trial in China (Alpelisib, Fulvestrant, Placebo)

Recruiting
  • Breast Neoplasms
  • Hefei, Anhui, China
  • +31 more
Dec 19, 2022

Breast Tumors Trial in Worldwide (Xentuzumab, Placebo, Everolimus)

Completed
Has Results
  • Breast Neoplasms
  • Chandler, Arizona
  • +53 more
Dec 13, 2022

Breast Tumors, Radiotherapy, Lymph Node Metastases Trial in Ghent (Prone Radiotherapy, Acceleration, Supine Radiotherapy)

Completed
  • Breast Neoplasms
  • +2 more
  • Prone Radiotherapy
  • +3 more
  • Ghent, Oost-Vlaanderen, Belgium
    Radiotherapy department, UZ Ghent
Dec 9, 2022

Cell-in-cell Structure in Breast Cancer Undergoing Neoadjuvant

Recruiting
  • Breast Neoplasms
  • Neoadjuvant therapy
  • Beijing, Beijing, China
    Beijing Shijitan Hospital, Capital Medical University
Dec 6, 2022

Breast Tumors Trial in Worldwide (PD-0332991, Letrozole, Placebo)

Active, not recruiting
Has Results
  • Breast Neoplasms
  • Bellflower, California
  • +304 more
Dec 6, 2022

Acute and Long-term Cardiovascular Toxicity After Modern

Recruiting
  • Breast Neoplasms
  • Cardiovascular Diseases
    • Trondheim, Norway
    • +1 more
    Dec 5, 2022

    Breast Tumors, Malignant Tumor of the Breast Trial in Multiple Locations (Trastuzumab, Pertuzumab, Vinorelbine, Paclitaxel,

    Terminated
    • Breast Neoplasms
    • Malignant Tumor of the Breast
    • Multiple Locations, Texas
      19 Sites
    Nov 29, 2022

    Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

    Recruiting
    • Breast Neoplasms
    • +10 more
    • Standard Therapy
    • +32 more
    • Birmingham, Alabama
    • +35 more
    Nov 17, 2022

    Abbreviated Breast MRI After BCT

    Active, not recruiting
    • Breast Neoplasms
    • Carcinoma, Intraductal, Noninfiltrating
      • Philadelphia, Pennsylvania
        UPenn
      Nov 18, 2022

      Breast Tumors Trial in Saint Louis (accelerated partial breast irradiation)

      Active, not recruiting
      • Breast Neoplasms
      • accelerated partial breast irradiation
      • Saint Louis, Missouri
        Washington University School of Medicine
      Nov 14, 2022

      Breast Tumors Trial in Worldwide (Abemaciclib, Fulvestrant, Placebo)

      Active, not recruiting
      Has Results
      • Breast Neoplasms
      • Fayetteville, Arkansas
      • +141 more
      Nov 15, 2022

      Breast Tumors Trial in Japan (E7090, Fulvestrant, Exemestane)

      Recruiting
      • Breast Neoplasms
      • Nagoya, Aichi, Japan
      • +10 more
      Nov 11, 2022

      Metastatic HER2+ Advanced Breast Cancer, Breast Tumors, Gastric or Gastroesophageal Junction Adenocarcinoma (GEC) Trial in

      Recruiting
      • Metastatic HER2+ Advanced Breast Cancer
      • +3 more
      • Harbin, Heilongjiang, China
      • +4 more
      Nov 15, 2022

      Breast Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane)

      Completed
      Has Results
      • Breast Neoplasms
      • Radium-223 dichloride (Xofigo, BAY88-8223)
      • +3 more
      • Yuma, Arizona
      • +93 more
      Nov 4, 2022

      Breast Tumors, Breast Cancer, Left Sided Breast Cancer Trial in Taipei (PERSBRA)

      Enrolling by invitation
      • Breast Neoplasms
      • +2 more
      • PERSBRA
      • Taipei, Taiwan
        Taipei Medical University Hospital
      Nov 3, 2022

      Breast Tumors Trial in Beijing (Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy

      Recruiting
      • Breast Neoplasms
      • Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy (26 Gy/5.2Gy/5)
      • Beijing, Beijing, China
        National Cancer Center/National Clinical Research Center for Can
      Nov 1, 2022

      Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

      Terminated
      Has Results
      • Breast Neoplasms
      • Saint Louis, Missouri
        Washington University School of Medicine
      Oct 31, 2022

      Breast Tumors, Tumor Metastasis Trial in Boston, Canton (CodaLytic)

      Not yet recruiting
      • Breast Neoplasms
      • Neoplasm Metastasis
      • CodaLytic
      • Boston, Massachusetts
      • +1 more
      Oct 28, 2022

      Breast Tumors Trial in Shanghai (Epirubicin, Docetaxel, cyclophosphamide)

      Completed
      • Breast Neoplasms
      • Shanghai, Shanghai, China
        Ruijin Hospital
      Oct 26, 2022

      The Canadian/US Integrative Oncology Study

      Active, not recruiting
      • Breast Neoplasms
      • +3 more
        • Scottsdale, Arizona
        • +11 more
        Oct 21, 2022

        Describe Breast Cancer Patient Population, Treatment, and

        Completed
        • Breast Cancer
        • +4 more
        • Palbociclib plus hormonal treatment - first line treatment
        • Palbociclib plus hormonal treatment - second line treatment
        • Rajpath Club Lane ,Gujarat, India, Ahmedabad, India
        • +5 more
        Oct 13, 2022